Clicky

Redhill Biopharma Ltd.(RDHL) News

Date Title
Dec 4 RedHill Announces New, Non-Dilutive External Funding of Entire RHB-107 COVID-19 300-Patient Phase 2 Study
Nov 27 RedHill Biopharma Announces FDA Grant of 5-Year U.S. Market Exclusivity for Talicia® with IP Protection Running to 2034
May 22 RedHill Provides R&D Update